← All Revvity, INC filings

Revvity, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NYSE
RVTY
Revvity, INC
SCHEDULE: T. Rowe Price Discloses 5% Stake in Revvity Inc.
T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.0% of Revvity Inc.'s common stock as of June 30, 2026.
NYSE
RVTY
Revvity, INC
SCHEDULE: Vanguard Reports 7.44% Stake in Revvity Inc.
Vanguard Capital Management disclosed a beneficial ownership of 8,326,862 shares, representing 7.44% of Revvity Inc.'s common stock as of March 31, 2026.
NYSE
RVTY
Revvity, INC
SCHEDULE: Vanguard Group Reports Zero Revvity Stake Post-Realignment
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Revvity Inc. following an internal realignment.
NYSE
RVTY
Revvity, INC
SCHEDULE: Janus Henderson Discloses 6.6% Stake in Revvity, Inc.
Janus Henderson Group plc has reported a 6.6% beneficial ownership stake in Revvity, Inc. through a Schedule 13G filing.
NYSE
RVTY
Revvity, INC
SCHEDULE: EdgePoint Investment Group Boosts Revvity Stake to 7.39%
EdgePoint Investment Group Inc. has reported a 7.39% beneficial ownership stake in Revvity, Inc., holding 8,574,280 common shares.
NYSE
RVTY
Revvity, INC
SCHEDULE 13G/A: T. Rowe Price Discloses 6.8% Stake in Revvity Inc.
T. Rowe Price Associates, Inc. has reported a beneficial ownership of 6.8% of Revvity Inc.'s common stock as an investment adviser.
NYSE
RVTY
Revvity, INC
SCHEDULE: EdgePoint Discloses 5.76% Stake in Revvity
EdgePoint Investment Group Inc. has reported a 5.76% beneficial ownership stake in Revvity, Inc., totaling 6,789,660 common shares.
NYSE
RVTY
Revvity, INC
SCHEDULE: Janus Henderson Discloses 6.1% Stake in Revvity
Janus Henderson Group plc has disclosed a 6.1% beneficial ownership stake in Revvity, Inc. through American Depositary Shares, held for investment purposes.
NYSE
RVTY
Revvity, INC
SCHEDULE 13G/A: T. Rowe Price Associates Discloses 8.0% Stake in Revvity Inc.
T. Rowe Price Associates, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.0% of Revvity Inc.'s common stock as of March 31, 2025.
NYSE
RVTY
Revvity, INC
SCHEDULE 13G/A: T. Rowe Price Associates Discloses 8.0% Stake in Revvity Inc.
T. Rowe Price Associates, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 8.0% of Revvity Inc.'s common stock as of March 31, 2025.
NYSE
RVTY
Revvity, INC
SCHEDULE 13G/A: T. Rowe Price Investment Management Discloses 18.7% Stake in Revvity Inc.
T. Rowe Price Investment Management, Inc. has filed an updated Schedule 13G, revealing a significant 18.7% beneficial ownership stake in life sciences company Revvity Inc.
NYSE
RVTY
Revvity, INC
SCHEDULE 13G/A: Janus Henderson Group Discloses 4.9% Passive Stake in Revvity Inc.
Janus Henderson Group plc has filed an amended Schedule 13G, disclosing a 4.9% beneficial ownership stake in Revvity Inc.'s common stock, held for investment purposes.
NYSE
RVTY
Revvity, INC
SCHEDULE 13G/A: Janus Henderson Group PLC Discloses 5.2% Passive Stake in Revvity Inc.
Janus Henderson Group PLC has filed an amended Schedule 13G, reporting a 5.2% beneficial ownership stake in Revvity Inc. as of December 31, 2024.
NYSE
RVTY
Revvity, INC
SCHEDULE 13G/A: T. Rowe Price Investment Management Discloses 17.1% Stake in Revvity Inc.
T. Rowe Price Investment Management, Inc. has filed an amended Schedule 13G, reporting a beneficial ownership of 17.1% of Revvity Inc.'s common stock as of December 31, 2024.